📢 Pharmidex at the 36th RSC BMCS Spring Symposium on Medicinal Chemistry 🧪
April 22, 2025

This annual symposium is a key event in the medicinal chemistry calendar, bringing together researchers and industry professionals to discuss cutting-edge advances in drug discovery.


Our team will be available to discuss how Pharmidex’s integrated services can support the development of novel therapeutics from early discovery through to candidate selection.


📍 Location: Hatfield, UK

 📅 Date: 24th April 2025

 🔗 www.pharmidex.com, https://lnkd.in/eZdCsd4M


We look forward to engaging with the scientific community and exploring new opportunities for collaboration. Visit our stand or contact [email protected]. 


See you there!

#HatfieldMedChem25 #Pharmidex #BMCS2025 #MedicinalChemistry #DrugDiscovery #ADME #Bioanalysis #CNS #DMPK #PharmaceuticalSciences #oncology #respiratory #ContractResearchOrganisation #CRO #Preclinical #Networking #Collaboration

Ian Knowles will be attending the Drug Delivery to the Lungs Conference

December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.

Pharmidex at "Recent Clinical Candidates and SMR Award Meeting"

December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!

Pharmidex will attend Genesis 2025 hosted by One Nucleus

December 2, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
More Posts